Lesson
Build the Disease Model
Seborrheic dermatitis reflects an interaction among sebum-rich skin, Malassezia, barrier function, individual susceptibility, and inflammation. Dandruff is the milder scalp-predominant end of the spectrum.
- Sebum-rich sites
- Malassezia
- Barrier function
- Inflammation
- Relapse
Scalp, face, ears, and chest
A normal resident in an altered host response
Turnover and lipid disruption amplify symptoms
Control and maintenance have different jobs
Reject the hygiene myth
Seborrheic dermatitis is not caused by being dirty and is not contagious. Harsh washing can injure the barrier and worsen a flare.
Place Malassezia correctly
Malassezia normally lives on human skin. The disease reflects host response and local ecology, not a simplistic claim that every patient has an infection.
Map the distribution
The scalp, brows, glabella, nasolabial folds, ears, beard area, central chest, and folds are common because they are sebum-rich or occluded.
Expect recurrence
Treatment can control scale, itch, and inflammation, but it does not permanently change susceptibility. Maintenance is often part of successful care.
Quick check
Lesson
Recognize the Pattern and Its Mimics
Morphology, distribution, age, hair findings, systemic symptoms, and host status determine whether a familiar flare can be treated or needs diagnosis.
- Scalp scale
- Facial folds
- Psoriasis
- Tinea capitis
- Red flags
Dandruff is the mild scalp end
Vehicle and steroid risk change
Hair loss or pustules change the diagnosis
Do not self-treat a dangerous pattern
Central, crown, or frontal geometry
Trigger history is central
Examine hairs, skin, and nails
Early treatment protects remaining follicles
Read the whole pattern
Scalp scale may be fine and white or greasy. Erythema can appear pink, red, violet, darker, or lighter than surrounding skin across skin tones.
Compare common mimics
Well-demarcated thick plaques suggest psoriasis. Annular lesions, broken hairs, alopecia, pustules, or lymphadenopathy raise concern for tinea capitis or another infection.
Inspect exposures
New dyes, fragrances, oils, adhesives, protective styles, cosmetics, and topical medicines can cause irritant or allergic contact dermatitis.
Escalate atypical disease
Pain, fever, purulence, scarring, rapid hair loss, eye pain, widespread eruption, immune compromise, or persistent failure requires clinical assessment.
Quick check
Lesson
Engineer a Scalp Shampoo Plan
Medicated shampoo is an active treatment, not ordinary hair washing. The ingredient, schedule, contact time, hair texture, and ability to reach the scalp determine success.
- Ketoconazole
- Ciclopirox
- Selenium sulfide
- Pyrithione zinc
- Keratolytics
Reduce the yeast-linked disease signal
Follow the exact label
Useful for selected thick scale
Leave on only as directed, then rinse
Use antifungal shampoos
Ketoconazole and ciclopirox reduce the yeast-linked disease signal. Prescription ciclopirox labeling uses twice-weekly application for four weeks with at least three days between applications in patients at least 16 years old.
Use OTC actives deliberately
Selenium sulfide and pyrithione zinc can reduce itching, flaking, scaling, irritation, and recurrence when used according to the specific label.
Use scale-directed options selectively
Salicylic acid can loosen scale. Coal tar can reduce scale and turnover but may smell, stain, discolor light hair, or increase photosensitivity.
Respect hair practice
Apply to the scalp rather than coating only the hair. A plan for tightly coiled hair may use a less frequent schedule while preserving adequate contact and maintenance.
Quick check
Lesson
Treat Skin Outside the Scalp
Facial, ear, beard, chest, and fold disease needs a vehicle that reaches affected skin without unnecessary ocular, mucosal, or irritant exposure.
- Ketoconazole cream
- Foam and gel
- Facial disease
- Folds
- Local tolerance
Thin application to affected skin
Vehicle can improve reach and adherence
External-use instructions still matter
Irritation can mimic a flare
Choose a skin vehicle
Creams suit localized glabrous skin. Foams and gels can help hair-bearing areas, but products with the same ingredient may have different ages, schedules, and approved uses.
Apply a thin layer
More product does not guarantee more effect. Extend only to the affected area and follow the exact label or clinician plan.
Protect sensitive boundaries
Keep topical antifungals away from eyes and mucosa unless the product is specifically designed for that site. Eyelid-margin disease deserves careful evaluation.
Distinguish irritation from disease
Burning, stinging, erythema, dryness, or contact dermatitis can follow topical treatment. Reassess a worsening site instead of repeatedly increasing exposure.
Quick check
Lesson
Control Inflammation Without Creating a New Problem
Inflammation can persist after antifungal therapy. Short rescue treatment should be separated from safer long-term maintenance.
- Topical corticosteroids
- Potency
- Face and folds
- Calcineurin inhibitors
- Exit strategy
Potency, site, and duration govern risk
Avoid prolonged unsupervised use
Off-label clinician-directed option
Do not let rescue therapy become routine
Use steroids as rescue
A low-potency topical corticosteroid can rapidly reduce itch and inflammation during a flare. Potency, vehicle, site, age, area, and duration determine safety.
Protect thin skin
Prolonged or potent corticosteroid use on the face, eyelids, ears, or folds can cause atrophy, telangiectasia, pigment change, acneiform eruption, and ocular harm.
Consider a steroid-sparing route
Clinician-directed tacrolimus or pimecrolimus can reduce inflammation on sensitive sites without steroid atrophy, but seborrheic dermatitis use is off-label and transient burning is common.
Define the exit
A rescue medicine should have a stop point. Continued prevention usually returns to antifungal, gentle skin care, or another maintenance plan.
Quick check
Lesson
Use Topical PDE4 Inhibition Precisely
Roflumilast foam offers once-daily nonsteroidal treatment for scalp and body disease, but it still requires exact indication, age, liver, interaction, and flammability screening.
- PDE4
- Cyclic AMP
- Foam 0.3 percent
- Once daily
- Liver impairment
Raises intracellular cyclic AMP
Treats itch, scale, and discoloration
Scalp and body application
Liver impairment and flammability matter
Connect target to effect
Roflumilast inhibits phosphodiesterase 4, increases intracellular cyclic AMP, and reduces inflammatory signaling.
Use the approved population
Current labeling indicates roflumilast foam 0.3 percent for seborrheic dermatitis in adults and pediatric patients at least 9 years old.
Apply correctly
Shake the can. Apply a thin layer once daily to dry affected scalp or body skin, rub in completely, and wash hands afterward.
Screen label hazards
The foam is contraindicated in moderate to severe liver impairment. Avoid fire, flame, and smoking during and immediately after application, and review relevant metabolic interactions.
Quick check
Lesson
Adapt Treatment to the Patient
Age, skin tone, hair texture, pregnancy, lactation, immune status, and neurologic disease change recognition, feasibility, evidence, and referral thresholds.
- Cradle cap
- Skin of color
- Tightly coiled hair
- Pregnancy and lactation
- High-risk host
Systemic exposure can rise
Use a deliberate site and duration plan
Use current product evidence, not retired letters
Nipple use requires a feeding plan
Prevent overheating
Visible-light protection can matter
Vehicle and ingredients differ
Retired letters do not decide care
Gentle scale care, no adult shampoo assumption
Build a feasible scalp schedule
Track pigment change and texture
Lower the threshold for evaluation
Lower threshold for clinical review
Change and protect more often
Use morphology, not prophylactic antifungal
Pressure and wound care may coexist
Evidence and labeling differ below age two
Retired letter categories are not used
Mebendazole data differ from other options
Select product and plan individually
Care for cradle cap gently
Infantile seborrheic dermatitis is often self-limited. Gentle baby shampoo, emollient-assisted loosening, and a soft brush can remove scale without force. Adult dandruff shampoo is not a default infant treatment.
Recognize across skin tones
Inflammation may be less visibly red and can leave hypo- or hyperpigmentation. Track texture, scale, itch, and pigment rather than relying on redness alone.
Respect hair structure and styling
Tightly coiled hair and protective styles may make frequent washing impractical or damaging. Agree on an effective schedule and vehicle rather than labeling the patient nonadherent.
Individualize higher-risk decisions
Use product-specific pregnancy and lactation data, age labeling, treated area, infant contact, immune status, and neurologic disease. Avoid retired pregnancy letters.
Quick check
Lesson
Turn the Label Into Safe Technique
Dandruff products differ in active ingredient, concentration, schedule, contact time, staining, irritation, photosensitivity, broken-skin warnings, and age limits.
- Active ingredient
- Contact time
- Eye exposure
- Hair discoloration
- Duplication
Avoid accidental duplication
Use product-specific contact time
Warnings vary by formulation
Stop or adjust when harm exceeds benefit
Identify the active
Brand families may sell multiple formulas. Confirm the active ingredient and strength before judging response or combining products.
Use product-specific contact
Wet or dry application, massage, contact time, rinse, frequency, and treatment length vary. A universal five-minute rule is unsafe.
Protect eyes and injured skin
External-use products can irritate eyes and broken or inflamed skin. Rinse eye exposure thoroughly and follow the product's warning language.
Anticipate cosmetic effects
Selenium sulfide and coal tar products can discolor some hair or stain materials. Tar can also increase photosensitivity. Discuss acceptability before prescribing the routine.
Quick check
Lesson
Build Control That Survives the Next Flare
Successful care measures symptoms and function, distinguishes induction from maintenance, and rechecks diagnosis, technique, adherence, and exposures when control fails.
- Induction
- Maintenance
- Trigger tracking
- Monitoring
- Referral
Start with an active regimen
Relapse is expected, not failure
Follow function as well as appearance
Recheck diagnosis, technique, and adherence
Define the phases
Induction suppresses active scale and inflammation. Maintenance may use intermittent medicated shampoo or another clinician-directed regimen after control.
Track meaningful outcomes
Record sites, itch, scale, pain, sleep, embarrassment, styling burden, pigment change, treatment tolerance, and recurrence rather than appearance alone.
Audit apparent failure
Confirm diagnosis, active ingredient, expiration, technique, contact time, schedule, site access, hair routine, new products, and adherence before escalating.
Know when to refer
Refer persistent, widespread, painful, infected, scarring, alopecic, ocular, infant, immunocompromised, or diagnostically uncertain disease. Abrupt severe disease can justify evaluation for an associated condition.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 112 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.